Skip to content

Study on Precision Ultrasound Assessment of Breast and Drainage Area Lymph Nodes

Research on the Application Value of Multimodal Ultrasound Technology in Precise Diagnosis, Treatment, and Evaluation of Breast Diseases and Drainage Area Lymph Nodes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107993
Enrollment
Unknown
Registered
2025-08-22
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer?Mastitis?Metastatic lymph nodes?Reactive hyperplastic lymph nodes

Interventions

Gold Standard:Pathological results from biopsy or surgical resection or confirmed through imaging follow-up
Index test:Multimodal Ultrasound Technology (B-mode UltrasoundColor Doppler Flow Imaging (CDFI)Power Doppler Imaging (PDI)Superb Microvascular Imaging (SMI)ElastographyContrast-Enhanced Ultrasound (CE

Sponsors

Chongqing University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Patients who underwent multimodal ultrasound examination of the breast and drainage area lymph nodes in our department (incorporating at least two or more modalities, such as conventional ultrasound + elastography or conventional ultrasound + contrast-enhanced ultrasound); 2.Ultrasonographic examination revealed abnormalities in the breast and/or drainage area lymph nodes. 3.All cases must have a definitive final diagnosis established, meeting either of the following criteria: pathologically confirmed or confirmed as benign lesions through imaging follow-up;

Exclusion criteria

Exclusion criteria: 1.Patients with incomplete imaging data; 2.Poor-quality images deemed unsuitable for meaningful retrospective analysis.

Design outcomes

Primary

MeasureTime frame
Area Under the ROC Curve, AUC;accuracy;sensitivity;specificity;

Countries

China

Contacts

Public ContactFang Li

Chongqing University Cancer Hospital

1768308607@qq.com+86 13808312288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026